Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Share-based Compensation (2023 - 2025)

Rallybio's Share-based Compensation history spans 3 years, with the latest figure at $1.0 million for Q3 2025.

  • For Q3 2025, Share-based Compensation fell 48.35% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $6.5 million, down 24.2%, while the annual FY2024 figure was $8.0 million, 26.8% down from the prior year.
  • Share-based Compensation for Q3 2025 was $1.0 million at Rallybio, down from $1.6 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $3.0 million in Q1 2023 and bottomed at $1.0 million in Q3 2025.
  • The 3-year median for Share-based Compensation is $2.0 million (2024), against an average of $2.1 million.
  • The largest YoY upside for Share-based Compensation was 10.01% in 2025 against a maximum downside of 48.35% in 2025.
  • A 3-year view of Share-based Compensation shows it stood at $2.5 million in 2023, then decreased by 22.99% to $2.0 million in 2024, then crashed by 46.66% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Share-based Compensation are $1.0 million (Q3 2025), $1.6 million (Q2 2025), and $1.9 million (Q1 2025).